IRWD Ironwood Pharmaceuticals, Inc.

16.06
+0  (3%)
Previous Close 15.64
Open 15.72
Price To book 34.53
Market Cap 2.37B
Shares 147,853,000
Volume 1,141,013
Short Ratio 8.97
Av. Daily Volume 1,408,220

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2a data due in 2017.
IW-1973
Type 2 diabetes
Phase 2a data due in 2017.
IW-1973
Type 2 diabetes
sNDA approval announced January 26, 2017.
Linaclotide 72 mcg dose for use in the treatment of adults
Chronic idiopathic constipation (CIC)
Phase 2b data released December 22, 2016. Phase 3 trials to be initiated in 2H 2017.
Linaclotide Colonic Release
Irritable Bowel Syndrome with Constipation (IBS-C)
Phase 2a data released April 2016. Development to be discontinued due to disappointing data
IW-9179
Gastroparesis
Phase 2b data due mid-2017.
IW-3718
Gastroesophageal reflux disease (GERD)

Latest News

  1. Are Options Traders Betting on a Big Move in Ironwood Pharmaceuticals (IRWD) Stock?
  2. Allergan and Ironwood Launch Campaign Designed to Empower the Nearly 64 Million Americans Estimated to Suffer from IBS and CIC to Talk About Bowel Health(1-5)
  3. Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : April 6, 2017
  4. Ironwood Pharmaceuticals Appoints Dr. Christopher Wright as Senior Vice President of Global Development and Chief Development Officer
  5. ETFs with exposure to Ironwood Pharmaceuticals, Inc. : April 5, 2017
  6. Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017
  7. Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
  8. Synergy Pharmaceuticals: Approval, Now What?
  9. Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
  10. Ironwood Pharmaceuticals Showcases Progress Delivering Innovative Medicines to Patients and Building a Top-Performing Commercial Biotech at R&D Day 2017
  11. ($$) Celebrating Failure in a Tough Drug Industry
  12. Ironwood Pharmaceuticals to Present at Cowen and Company 37th Annual Health Care Conference
  13. Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017
  14. Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
  15. Ironwood reports 4Q loss
  16. Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2016 Investor Update
  17. Drug Stocks Q4 Earnings Lineup for Feb 21: IRWD, MNTA, EXAS
  18. 5 Drug Stocks Poised to Beat Earnings Estimates in Q4
  19. Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2016 Investor Update Call